98 related articles for article (PubMed ID: 7200970)
1. Depressed pulmonary removal of [3H]prostaglandin E1 after prolonged cardiopulmonary bypass.
Pitt BR; Hammond GL; Gillis CN
J Appl Physiol Respir Environ Exerc Physiol; 1982 Apr; 52(4):887-92. PubMed ID: 7200970
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced impairment of pulmonary [3H]prostaglandin E1 removal in vivo.
Pitt BR; Forder JR; Gillis CN
J Pharmacol Exp Ther; 1983 Nov; 227(2):531-7. PubMed ID: 6195329
[TBL] [Abstract][Full Text] [Related]
3. Influence of the lung on arterial levels of endogenous prostaglandins E and F.
Pitt BR; Gillis CN; Hammond GL
J Appl Physiol Respir Environ Exerc Physiol; 1981 Jun; 50(6):1161-7. PubMed ID: 7263376
[TBL] [Abstract][Full Text] [Related]
4. Depressed prostaglandin E1 and 5-hydroxytryptamine removal in patients with adult respiratory distress syndrome.
Gillis CN; Pitt BR; Wiedemann HP; Hammond GL
Am Rev Respir Dis; 1986 Oct; 134(4):739-44. PubMed ID: 3532886
[TBL] [Abstract][Full Text] [Related]
5. Effects and arterial concentration of prostaglandin E1 during cardiopulmonary bypass.
Okuda M; Faruhashi K; Konishi K; Muneyuki M
Eur J Anaesthesiol; 1991 Mar; 8(2):129-34. PubMed ID: 1874208
[TBL] [Abstract][Full Text] [Related]
6. The effect of prostaglandin E1 in patients undergoing clinical cardiopulmonary bypass.
van den Dungen JJ; Karliczek GF; Brenken U; van der Heide JN; Wildevuur CR
Ann Thorac Surg; 1983 Apr; 35(4):406-14. PubMed ID: 6682305
[TBL] [Abstract][Full Text] [Related]
7. Fate of prostaglandins E(1) and A(1) in the human pulmonary circulation.
Hammond GL; Cronau LH; Whittaker D; Gillis CN
Surgery; 1977 Jun; 81(6):716-22. PubMed ID: 871015
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of prostaglandin E1 during cardiopulmonary bypass in infants and children.
Kawamura M; Minamikawa O; Yokochi H; Maki S; Yasuda T; Mizukawa Y
Jpn J Surg; 1982; 12(1):19-25. PubMed ID: 7200161
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic side effects of prostaglandin E1 in patients before and during cardiopulmonary bypass.
Karliczek G; van den Dungen JJ; Brenken U; Eijsman L; Kootstra GJ; Homan van der Heide JN; Wildevuur CR
Thorac Cardiovasc Surg; 1981 Feb; 29(1):55-9. PubMed ID: 6164120
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of [2-14C]prostaglandin E1 on passage through the pulmonary circulation.
Dawson CA; Cozzini BO; Lonigro AJ
Can J Physiol Pharmacol; 1975 Aug; 53(4):610-5. PubMed ID: 1100206
[TBL] [Abstract][Full Text] [Related]
11. [Effects of prostaglandin E1 infusion during cardiopulmonary bypass].
Okuda M; Ohi Y; Utsunomiya H; Kurata M; Konishi K; Muneyuki M
Masui; 1989 Aug; 38(8):1036-41. PubMed ID: 2810697
[TBL] [Abstract][Full Text] [Related]
12. Depression of pulmonary metabolic function by cardiopulmonary bypass procedures increases levels of circulating norepinephrine.
Pitt BR; Gillis CN; Hammond GL
Ann Thorac Surg; 1984 Nov; 38(5):508-13. PubMed ID: 6497479
[TBL] [Abstract][Full Text] [Related]
13. [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis].
Yamaguchi H; Shimizu T; Akutsu H; Kawachi K; Osada K; Fujikawa T; Suesada H; Hirayama T; Ishimaru S; Furukawa K
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):625-9. PubMed ID: 2373896
[TBL] [Abstract][Full Text] [Related]
14. Further identification of PGE1 metabolites formed in the cat lung.
Cozzini BO; Dawson CA
Can J Physiol Pharmacol; 1977 Apr; 55(2):311-3. PubMed ID: 871963
[TBL] [Abstract][Full Text] [Related]
15. [The renal function protection of prostaglandin E1 from hemolysis caused by cardiopulmonary bypass].
Yang G; Xiao D; Wang J
Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):695-7. PubMed ID: 9772542
[TBL] [Abstract][Full Text] [Related]
16. Influence of plasma protein on the inhibitory effects of indocyanine green and bromcresol green on pulmonary prostaglandin E1 extraction.
Dawson CA; Linehan JH; Rickaby DA; Roerig DL
Br J Pharmacol; 1984 Mar; 81(3):449-55. PubMed ID: 6538103
[TBL] [Abstract][Full Text] [Related]
17. Selective effect of microembolization on pulmonary removal of biogenic amines.
Flink JR; Pitt BR; Hammond GL; Gillis CN
J Appl Physiol Respir Environ Exerc Physiol; 1982 Feb; 52(2):421-7. PubMed ID: 7061295
[TBL] [Abstract][Full Text] [Related]
18. [The effects of prostaglandin E1 on systemic and cerebral oxygenation before and during cardiopulmonary bypass].
Kawahara F; Kadoi Y
Masui; 2002 Feb; 51(2):128-33. PubMed ID: 11889777
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.
Nandiwada P; Hyman AL; Feigen LP; Kadowitz PJ
Arch Int Pharmacodyn Ther; 1980 May; 245(1):118-28. PubMed ID: 7190813
[TBL] [Abstract][Full Text] [Related]
20. In vivo disposition of prostaglandin E1 via pharmacokinetic characterization of its pulmonary metabolite.
Verburg M; Bothwell W; Daniels EG; Fitzpatrick FA
J Cardiovasc Pharmacol; 1982; 4(6):980-5. PubMed ID: 6185792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
